BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16835260)

  • 21. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
    Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
    Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.
    Viskochil DH
    J Clin Invest; 2003 Dec; 112(12):1791-3. PubMed ID: 14679174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.
    Lasater EA; Bessler WK; Mead LE; Horn WE; Clapp DW; Conway SJ; Ingram DA; Li F
    Hum Mol Genet; 2008 Aug; 17(15):2336-44. PubMed ID: 18442999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
    Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
    Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.
    Ferguson MJ; Rhodes SD; Jiang L; Li X; Yuan J; Yang X; Zhang S; Vakili ST; Territo P; Hutchins G; Yang FC; Ingram DA; Clapp DW; Chen S
    Pediatr Blood Cancer; 2016 Feb; 63(2):206-13. PubMed ID: 26375012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.
    Ingram DA; Yang FC; Travers JB; Wenning MJ; Hiatt K; New S; Hood A; Shannon K; Williams DA; Clapp DW
    J Exp Med; 2000 Jan; 191(1):181-8. PubMed ID: 10620616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.
    Sherman LS; Atit R; Rosenbaum T; Cox AD; Ratner N
    J Biol Chem; 2000 Sep; 275(39):30740-5. PubMed ID: 10900196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nf1 haploinsufficiency augments angiogenesis.
    Wu M; Wallace MR; Muir D
    Oncogene; 2006 Apr; 25(16):2297-303. PubMed ID: 16288202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study.
    Friedrich RE; Holstein AF; Middendorff R; Davidoff MS
    Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis.
    Wang S; Wilkes MC; Leof EB; Hirschberg R
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F142-9. PubMed ID: 19846571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of
    Burks CA; Rhodes SD; Bessler WK; Chen S; Smith A; Gehlhausen JR; Hawley ET; Jiang L; Li X; Yuan J; Lu Q; Jacobsen M; Sandusky GE; Jones DR; Clapp DW; Blakeley JO
    Mol Cancer Ther; 2019 Dec; 18(12):2321-2330. PubMed ID: 31527226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma.
    Kluwe L; Friedrich R; Mautner VF
    Genes Chromosomes Cancer; 1999 Mar; 24(3):283-5. PubMed ID: 10451710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of PLCγ/AKT/IκBα/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma.
    Xu J; Zhang H; Li C; Du H; Shu M; Jia J
    Life Sci; 2019 Dec; 239():117079. PubMed ID: 31756343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
    Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
    Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2012 Nov; 167(5):1098-105. PubMed ID: 22591006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.